Compare ATON & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATON | CPHI |
|---|---|---|
| Founded | 1973 | N/A |
| Country | British Virgin Islands | China |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8M | 6.1M |
| IPO Year | N/A | 2008 |
| Metric | ATON | CPHI |
|---|---|---|
| Price | $0.37 | $0.56 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 539.3K | 18.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 70.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,528,929.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.35 | $0.12 |
| 52 Week High | $13.80 | $14.00 |
| Indicator | ATON | CPHI |
|---|---|---|
| Relative Strength Index (RSI) | 35.90 | 27.42 |
| Support Level | $0.36 | N/A |
| Resistance Level | $3.30 | $1.88 |
| Average True Range (ATR) | 0.05 | 0.05 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 10.83 | 19.86 |
AlphaTON Capital Corp is a specialized digital asset treasury company focused on building and managing a strategic reserve of TON tokens and developing the Telegram ecosystem. The company implements a comprehensive treasury strategy that combines direct token acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. Through its operations, it provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.